Skip to the page

Data / Form D filings / Protego Biopharma, Inc.

Protego Biopharma, Inc.: Form D filings

Protego Biopharma, Inc., a health care company in San Diego, CA, filed 3 Form D notices with the SEC between 2019 and 2025. The latest, on December 3, 2025, reports $32.9 million sold of a $130.4 million offering to 18 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
10945 VISTA SORRENTO PARKWAY, SUITE 150, San Diego, CA, 92130
Phone
(858) 355-9290
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1796909

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 3, 2025New notice$130,442,180$32,942,190$97,499,99018Oct 17, 2025sec.gov
Oct 28, 2021New notice$51,047,342$51,047,3426Oct 19, 2021sec.gov
Dec 17, 2019New notice$1,000,012$1,000,0123Dec 6, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
TIM J. LOHOFFDirector
EDWARD J. HURWITZDirector
HANK MICHAEL PETRASSIExecutive Officer
JANWILLEM J. NAESENSDirector
SAOUSSEN J. BEN HALIMADirector
LAURA J. BRASSDirector
JEFFERY J. KELLYDirector
Brent J. WarnerExecutive Officer, Director
SHELLEY J. CHUDirector
HELEN J. KIMDirector

Other health care companies in California that filed recently

Every Form D from the week of Dec 1, 2025 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Protego Biopharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.